Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 18, 2013

View Archived Issues

International trial of rhNGF begins in the treatment of neurotrophic keratitis

Roche presents potential predictivity of preclinical cancer models

177Lu-J-591 shows promising antitumor activity at the MTD of 70 mCi/m2

Shin Nippon Biomedical Laboratories and Kyoto University enter agreement

Mylan enters generic insulin agreement with Biocon

Antitumor activity demonstrated for TRAIL-inducing compound TIC-10

Dako launches nontoxic FISH assay for cancer diagnosis in U.S.

Third Rock Ventures launches new company with a focus on cancer immunotherapy

Emory University and Health Research patent new TAK1 inhibitors

Novartis presents final results of a phase II study of dovitinib in urothelial cancer

FDA grants orphan drug status to OSE-2101

GlaxoSmithKline presents novel Lp-PLA2 inhibitors

Nerviano Medical Sciences divulges new protein kinase inhibitors

Novel c-Kit inhibitors presented by AB Science

Researchers at Allergan synthesize new alpha-adrenoceptor agonists

Phase II results for linsitinib in mCRPC presented

Livalo OD tablets approved in Japan for hypercholesteremia

FDA advisory committee recommends approval of contrast agent Dotarem

FDA accepts Oralair BLA for review

Piromelatine shows promise in phase II insomnia trial

Verastem compounds target cancer stem cells

FDA approves Zortress in new indication

Scientists at Grunenthal prepare novel TRPV1 ligands

Lilly and QIAGEN to collaborate on companion diagnostics

FDA grants priority review to dolutegravir NDA

Phase II trial of Cogane in Parkinson's disease misses endpoints

FDA approves Argus II Retinal Prosthesis System for patients with advanced retinitis pigmentosa

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Anticancer drug exerts potent HIV antiviral effects
BioWorld Science
A new isoform of proliferating cell nuclear antigen (PCNA) – cancer-associated PCNA (caPCNA) – that is specifically expressed in cancer tissues has been reported....